CVS Health Corporation $CVS Shares Purchased by Vestmark Advisory Solutions Inc.

Vestmark Advisory Solutions Inc. increased its stake in CVS Health Corporation (NYSE:CVS) by 154.1% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 16,185 shares of the pharmacy operator’s stock after acquiring an additional 9,815 shares during the quarter. Vestmark Advisory Solutions Inc.’s holdings in CVS Health were worth $1,220,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Harbor Capital Advisors Inc. boosted its stake in CVS Health by 72.1% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the period. Corundum Trust Company INC purchased a new position in shares of CVS Health during the third quarter valued at $29,000. Front Row Advisors LLC lifted its stake in CVS Health by 436.5% in the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 371 shares in the last quarter. Twin Peaks Wealth Advisors LLC acquired a new stake in CVS Health during the 2nd quarter worth about $36,000. Finally, SOA Wealth Advisors LLC. grew its stake in CVS Health by 36.9% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after acquiring an additional 131 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Performance

NYSE:CVS opened at $76.12 on Thursday. The firm has a market capitalization of $96.84 billion, a PE ratio of 55.16, a PEG ratio of 0.77 and a beta of 0.50. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. CVS Health Corporation has a 1 year low of $58.35 and a 1 year high of $85.15. The firm’s fifty day simple moving average is $78.35 and its 200 day simple moving average is $77.02.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. During the same period last year, the business posted $1.19 earnings per share. The firm’s revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, sell-side analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were paid a $0.665 dividend. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. CVS Health’s dividend payout ratio (DPR) is presently 192.75%.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. The Goldman Sachs Group upped their price objective on shares of CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. Jefferies Financial Group increased their price objective on CVS Health from $92.00 to $98.00 in a report on Thursday, October 30th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of CVS Health in a research note on Wednesday, December 10th. Barclays boosted their price target on CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. Finally, Wall Street Zen cut shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Nineteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and a consensus target price of $94.91.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.